Mustafa Arici
Mustafa Arici is an expert in Nephrology at Hacettepe University (Turkey). Mustafa Arici has authored 310 publications, the most recent in 2026, and is an investigator in 6 clinical trials. SLR score: 811 (community average: 125). How the SLR is computed.
LeadR Profile
Nephrology
Subspecialties: Transplantation - Cardiology - Urology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 310
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome. PMID 42794744 — lipoproteins, phenotype, kidney, cholesterol, therapeutics, lipoprotein(a), cholesterol, hdl, metabolic syndrome | Int J Mol Sci | 2026 | 0 |
| Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry. PMID 42720721 — diabetes mellitus, registries, kidney diseases, safety, serum, heart failure, heart, albuminuria, heart failure, diastolic, kidney, heart failure, systolic, diabetes mellitus, type 2 | Cardiovasc Drugs Ther | 2026 | 0 |
| Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study. PMID 42693414 — kidney diseases, laboratories, diabetic nephropathies, albuminuria, kidney, therapeutics | BMC Nephrol | 2026 | 0 |
| Uncontrolled Hypertension in Cardio-Renal-Metabolic Diseases: Real-World Insights on Patient Profiles and Management Patterns From iCaReMe Global Registry. PMID 42694927 — diabetes mellitus, registries, hypertension, metabolic diseases, antihypertensive agents, obesity, risk factors, diuretics, therapeutics, diabetes mellitus, type 2 | Int J Hypertens | 2026 | 0 |
| Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort. PMID 42592375 — kidney diseases, hyperkalemia, serum, diabetic nephropathies, kidney, machine learning, learning, mineralocorticoid receptor antagonists, diabetes complications | Clin Kidney J | 2026 | 0 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map